Streetbeat News

Analyst Ratings

SE

Over the past 3 months, 12 analysts have published their opinion on Sea (NYSE:SE) stock. The company has an average price target of $55.33, a decrease of 30.4% from the previous average price target of $79.50. The majority of analysts are somewhat bullish on the stock.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 7:00 pm

EXC

Exelon (NASDAQ:EXC) has received 4 somewhat bullish and 1 indifferent analyst ratings in the last quarter. The company's average 12-month price target is $45.2, a decrease of 4.34% from the previous average price target of $47.25.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 7:00 pm

SILK

Oppenheimer has initiated coverage on Silk Road Medical Inc (NASDAQ:SILK) with an Outperform rating and a price target of $30. Silk Road Medical has pioneered the Transcarotid Artery Revascularization (TCAR) method for stroke prevention, leading to impressive revenue growth. However, a CMS proposal for equal reimbursement for TCAR and another method has led to a revision in SILK's projections. The company's shares are up 3.33% at $19.22.

Portfolio Pulse from Vandana Singh

September 06, 2023 | 6:52 pm

BIIB

DNLI

B Riley Securities initiated coverage on Denali Therapeutics Inc (DNLI) with a Buy rating and a price target of $38. The analysts are optimistic about Denali's proprietary blood-brain barrier (BBB) shuttling platform approaches, which enables the safe, efficient, and effective delivery of complex large and small molecules. The emerging clinical datasets from DNLI's programs, whether independently owned or in collaboration, are anticipated to drive value in the coming quarters and years. Partnered programs, especially for Biogen Inc's (BIIB) ATV-Abeta (for Alzheimer's) and SAR443820 (for ALS), have been underestimated.

Portfolio Pulse from Vandana Singh

September 06, 2023 | 6:45 pm

COST

Costco Wholesale's (NYSE:COST) short percent of float has fallen 3.19% since its last report, with 4.04 million shares sold short, which is 0.91% of all regular shares available for trading. This decrease in short interest could signal a more bullish sentiment towards the stock. Compared to its peers, Costco has less short interest as a percentage of float, with an average of 3.27%.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 6:45 pm

AJG

Arthur J. Gallagher's (NYSE:AJG) short percent of float has risen 11.84% since its last report, with 1.59 million shares sold short, which is 0.85% of all regular shares available for trading. It would take traders 2.49 days to cover their short positions on average. The company's peer group average for short interest as a percentage of float is 3.12%, indicating less short interest than most of its peers.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 6:45 pm

ING

ING Groep's short percent of float has fallen 14.29% since its last report, with 4.23 million shares sold short, which is 0.12% of all regular shares available for trading. This decrease in short interest could signal a more bullish sentiment towards the stock. Compared to its peers, ING Groep has less short interest.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 6:45 pm

NX

Benchmark analyst Reuben Garner has reiterated a Buy rating on Quanex Building Products Corporation (NYSE:NX) and raised the price target to $33. The company's Q3 results beat estimates with record quarterly margins due to solid operational controls. The strong FCF outlook has led the analyst to predict potential opportunistic buybacks or a dividend increase. However, inflationary pressures and a tepid macro view could lead to a mixed FY24.

Portfolio Pulse from Nabaparna Bhattacharya

September 06, 2023 | 6:41 pm

PHG

RMD

Needham has upgraded ResMed Inc (RMD) from a Hold to Buy rating with a price target of $180. ResMed's shares are down 31% since August due to concerns about the potential for GLP-1 obesity drugs to reduce demand for ResMed's sleep therapy devices and Philips' (PHG) possible re-entry into the flow generator market. However, Needham believes that both impacts will likely be small and that ResMed can sustain 5-7% revenue growth above its large-cap peers.

Portfolio Pulse from Vandana Singh

September 06, 2023 | 6:39 pm

CSCO

A significant bullish stance has been taken on Cisco Systems (NASDAQ:CSCO) by a large investor, as observed from publicly available options history. The overall sentiment of these big-money traders is split between 63% bullish and 36% bearish. Whales have been targeting a price range from $52.5 to $60.0 for Cisco Systems over the last 3 months. Several experts have maintained their positive ratings on Cisco Systems, with price targets ranging from $58 to $65.

Portfolio Pulse from Benzinga Insights

September 06, 2023 | 6:32 pm